Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lanolin hydrous is a purified, fat-like substance obtained from the wool of sheep (*Ovis aries*), containing between 25% and 30% water. It is primarily used as an emollient and occlusive agent in topical formulations to treat or prevent dry, rough, scaly, itchy skin and minor skin irritations such as diaper rash or skin burns from radiation therapy. Lanolin works by forming an oily layer on the surface of the skin that traps water, thereby increasing skin hydration. Dr. Kulich Pharma distributes this substance as a pharmaceutical raw material (Adeps lanae cum aqua) for use in compounding ointments and other topical medicinal products.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lanolin hydrous.